search
Back to results

Deworming and Vitamin A (DEVTA) Prepilot Study

Primary Purpose

Malnutrition, Worm Infestation, Under-Fives

Status
Completed
Phase
Phase 3
Locations
India
Study Type
Interventional
Intervention
Albendazole (400 mg) and/or Vitamin a
Sponsored by
King George's Medical University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional health services research trial for Malnutrition focused on measuring Deworming, Malnutrition, children, Community, India

Eligibility Criteria

1 Year - 5 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Local residents
  • Aged 1-5 years
  • Informed written parental consent

Exclusion Criteria:

  • Refusal to give consent
  • prior enrollment in the study

Sites / Locations

  • Lucknow Commission

Outcomes

Primary Outcome Measures

Change in weight in 2 years

Secondary Outcome Measures

Secondary: Weight and Height gain in underweight, stunted and wasted children

Full Information

First Posted
November 4, 2006
Last Updated
November 6, 2006
Sponsor
King George's Medical University
Collaborators
United States Agency for International Development (USAID)
search

1. Study Identification

Unique Protocol Identification Number
NCT00396500
Brief Title
Deworming and Vitamin A (DEVTA) Prepilot Study
Official Title
To Assess the Effectiveness of Six-Monthly Deworming With Vitamin A Administration on Growth in 1-5 Year Old Children in the Urban Slums of Lucknow
Study Type
Interventional

2. Study Status

Record Verification Date
November 2006
Overall Recruitment Status
Completed
Study Start Date
April 1994 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 1996 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
King George's Medical University
Collaborators
United States Agency for International Development (USAID)

4. Oversight

5. Study Description

Brief Summary
Background. More than a third of the world's population is infected with intestinal nematodes. A majority of these infections occur in children. Current control approaches emphasise treatment of school age children, and there is a lack of information on the effects of deworming preschool childrenSetting: Within the Integrated Child Development System (ICDS) infrastructure in urban Lucknow (UP), IndiaDesign: Open Labeled randomised trialHypothesis: Our study hypothesis was that albendazole administration six monthly, as a single 400 mg dose in syrup, by the existing health care delivery system would be a practicable way to achieve mass deworming of preschool children and this might result in an improvement in weight gain of preschool childrenIntervention One group will receive usual health care by the existing health care staff, which included six monthly administration of Vitamin A concentrate. The other group will receive, in addition, 400 mg of albendazole (Zentel, Smith Kline & Beecham) in 10 ml syrup form. Five such doses will be given at six monthly intervals for 2 years.Main objective: To assess the impact of 6 monthly deworming on weight and height gain at the end of 2 years in children aged 1 to 5 years of age Main outcomes measures: Weight gain in 2 yearsInclusion criteria: Children 1 to 5 years, whose guardians give written informed consent. Exclusion criteria: Those not consentingSample size: Sample size was calculated for a continuous outcome. For a standardized effect size of 0.1, with a power of 80% and an alpha level of 0.05, using a 2-tailed t test, taking into account design effect, about 2000 children will be included in each arm.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malnutrition, Worm Infestation, Under-Fives
Keywords
Deworming, Malnutrition, children, Community, India

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
4000 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Albendazole (400 mg) and/or Vitamin a
Primary Outcome Measure Information:
Title
Change in weight in 2 years
Secondary Outcome Measure Information:
Title
Secondary: Weight and Height gain in underweight, stunted and wasted children

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Local residents Aged 1-5 years Informed written parental consent Exclusion Criteria: Refusal to give consent prior enrollment in the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shally Awasthi, MD, DNB
Organizational Affiliation
Dept of Pediatrics, King George's Medical University, Lucknow, India
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lucknow Commission
City
Lucknow
State/Province
Uttar Pradesh
ZIP/Postal Code
226003
Country
India

12. IPD Sharing Statement

Citations:
PubMed Identifier
18414647
Citation
Awasthi S, Peto R, Pande VK, Fletcher RH, Read S, Bundy DA. Effects of deworming on malnourished preschool children in India: an open-labelled, cluster-randomized trial. PLoS Negl Trop Dis. 2008 Apr 16;2(4):e223. doi: 10.1371/journal.pntd.0000223.
Results Reference
derived

Learn more about this trial

Deworming and Vitamin A (DEVTA) Prepilot Study

We'll reach out to this number within 24 hrs